Trials / Completed
CompletedNCT03105921
Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma
Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the use of irreversible electroporation in the treatment of locally advanced cancers of the head of pancreas with vascular spread. This technique would allow to treat the unresectable part of the tumor to make it more accessible for a secondary surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NanoKnife | The aim of the treatment is to sourround the tumour with two to six needles and to deliver a very high voltage current (3000 volts in 70 to 80 microseconds pulses) by a generator synchronized with an electrocardiogram. |
Timeline
- Start date
- 2014-10-24
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2017-04-10
- Last updated
- 2022-03-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03105921. Inclusion in this directory is not an endorsement.